Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse Effects.
Chadwick J. et al, (2025), J Clin Pharmacol
Missing Pieces of the Puzzle to Address Market Failures for Antibiotics: Delinked Payment Systems and Insurance Value.
Hawkins N. et al, (2025), Pharmacoecon Open
A systematic review of in vivo brain insulin resistance biomarkers in humans
Reid G. et al, (2025), Biomarkers in Neuropsychiatry, 12
Long-term outcomes following alternative second-line oral glucose-lowering treatments: Results from the real-world progression in type 2 diabetes mellitus United Kingdom (RAPIDS-UK) model.
Carroll OU. et al, (2025), Diabetes, obesity & metabolism
Glucocorticoid-induced hyperglycaemia in hospitalised adults: A matched cohort study (2013-2023).
Golubic R. et al, (2025), Diabetes Obes Metab
Response to Comments on Maddaloni et al. Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL. Diabetes Care 2025;48:235-242.
Maddaloni E. et al, (2025), Diabetes Care, 48, e61 - e62
Risk factors for bone fractures in type 2 diabetes and the impact of once-weekly exenatide: Insights from an EXSCEL post-hoc analysis.
Maddaloni E. et al, (2025), Diabetes Res Clin Pract
Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-Analysis.
Hanlon P. et al, (2025), JAMA, 333, 1062 - 1073
Effects of intensive blood pressure treatment on orthostatic hypertension: individual level meta-analysis.
Juraschek SP. et al, (2025), BMJ, 388
Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities
Loesch DP. et al, (2025), Nature Communications, 16
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
De Giorgi R. et al, (2025), Nature Mental Health, 3, 354 - 373
Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL.
Maddaloni E. et al, (2025), Diabetes Care, 48, 235 - 242
The Science of Diabetes and a Life of Trials: The 2024 Banting Medal for Scientific Achievement Award Lecture.
Holman RR., (2025), Diabetes, 74, 164 - 174
The legacy effect of hyperglycaemia in type 2 diabetes - Authors' reply.
Adler AI. et al, (2025), Lancet, 405
Cardiovascular Risk Prediction Scores in Type 1 Diabetes: A Systematic Review and Meta-Analysis.
Erqou S. et al, (2025), JACC Adv, 4